- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07751731
Survey to Determine Incarcerated Persons' Views on Surrogate Decision Making
Survey to Determine Incarcerated Persons Views on Surrogate Decision-Making
Background:
About 180,000 of the people in US prisons are over 55 years old. Aging people often cannot make medical decisions on their own. People who cannot make their own decisions must rely on a "surrogate." A surrogate is someone who helps the person's doctor make decisions for them. Researchers want to conduct a survey to ask people in prison who they would like to be their surrogates. But first, they need to find out if their survey questions are clear and easy to understand.
Objective:
To get imprisoned people's feedback on survey questions about surrogate decision making.
Eligibility:
People currently imprisoned in a US facility with access to Edovo. They must be able to read and write in English.
Design:
Participants will answer 26 survey questions. The questions will be on the Edovo Learn software platform. After each question, they will be asked: "Was this question clear? If not, please explain in the box below what you found unclear. Also, if you have any suggestions for how we might make the question clearer, please include them."
Participants will be asked to imagine themselves in a situation where they cannot make their own medical decisions. They may skip questions or stop the survey if they want. No information that identifies them will be collected.
The survey will take about 15 minutes.
Panoramica dello studio
Descrizione dettagliata
Study Description:
Currently, different states have different practices for surrogate decision-making for incarcerated persons who are not able to make their own decisions. These differences raise the challenge of determining which approach or approaches are the best. To address this issue, our research team has developed a questionnaire for incarcerated persons. This questionnaire will be integrated into a software application known as Edovo (https://www.edovo.org/), which is tailored for use in correctional facilities. This research aims to gather incarcerated persons" preferences related to surrogate decision-making. The study team hopes to identify best practices that could inform practices and policies across states, ultimately enhancing the support provided to this vulnerable population.
Objectives:
Primary Objective:
Explore incarcerated persons' views regarding surrogate decision-making if they become unable to make their own medical decisions.
Endpoints:
Primary Endpoints:
- Describe incarcerated persons' preferences for surrogate decisionmakers if they become unable to make their own medical decisions.
- The proportion of incarcerated persons who endorse the use of a patient preference predictor (PPP) for surrogate decision-making if they become unable to make their own medical decisions.
Secondary Endpoint:
The discrepancy between incarcerated persons who endorse the use of a PPP in general, but not for their own treatment.
Tipo di studio
Iscrizione (Stimato)
Contatti e Sedi
Contatto studio
- Nome: David Wendler, Ph.D.
- Numero di telefono: (301) 496-2429
- Email: dwendler@mail.cc.nih.gov
Luoghi di studio
-
-
Maryland
-
Bethesda, Maryland, Stati Uniti, 20892
- Reclutamento
- National Institutes of Health Clinical Center
-
Contatto:
- David Wendler, Ph.D.
- Numero di telefono: 301-496-2429
- Email: dwendler@mail.cc.nih.gov
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Adults who are currently incarcerated in the United States
Descrizione
- INCLUSION CRITERIA:
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Currently incarcerated in a United States facility with Edovo educational tablets
- Ability to understand the consent form and survey
- Willingness to give informed consent
EXCLUSION CRITERIA:
An individual who meets any of the following criteria will be excluded from participation in this study:
1. Inability to read or write in English
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: OTHER
- Prospettive temporali: CROSS_SECTIONAL
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Incarcerated adults
Adults who are incarcerated in the United States |
Tablet based survey |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Views on surrogates
Lasso di tempo: end of study
|
Incarcerated persons preferences for surrogate decision-makers if they become unable to make their own medical decisions. |
end of study
|
|
Views on PPP
Lasso di tempo: end of study
|
Proportion of incarcerated persons who endorse the use of a PPP for medical decision-making for incarcerated persons who become unable to make their own medical decisions. |
end of study
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: David Wendler, Ph.D., National Institutes of Health Clinical Center (CC)
Pubblicazioni e link utili
Pubblicazioni generali
- Batbold S, Duke JD, Riggan KA, DeMartino ES. Decision-Making for Hospitalized Incarcerated Patients Lacking Decisional Capacity. JAMA Intern Med. 2024 Jan 1;184(1):28-35. doi: 10.1001/jamainternmed.2023.5794.
- Helmly V, Garica M, Williams B, Howell BA. A review and content analysis of U.S. Department of Corrections end-of-life decision making policies. Int J Prison Health. 2022 Jun 2;18(2):165-175. doi: 10.1108/IJPH-06-2021-0060. Epub 2021 Dec 27.
- Earp BD, Porsdam Mann S, Allen J, Salloch S, Suren V, Jongsma K, Braun M, Wilkinson D, Sinnott-Armstrong W, Rid A, Wendler D, Savulescu J. A Personalized Patient Preference Predictor for Substituted Judgments in Healthcare: Technically Feasible and Ethically Desirable. Am J Bioeth. 2024 Jul;24(7):13-26. doi: 10.1080/15265161.2023.2296402. Epub 2024 Jan 16.
- Pope TM. Making medical decisions for patients without surrogates. N Engl J Med. 2013 Nov 21;369(21):1976-8. doi: 10.1056/NEJMp1308197. No abstract available.
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 10002491
- 002491-CC
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
No individual participant data will be collected.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .